Shah‐Jalal Sarker
Shah‐Jalal Sarker publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Oncology, on topics such as Renal cell carcinoma treatment, Testicular diseases and treatments and Childhood Cancer Survivors' Quality of Life.
- World rank
- #1,843,653 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #137,235 of 367,258
- Works
- 76
- Citations
- 1.8k
- Citations per work
- 23.8
What does Shah‐Jalal Sarker research?
Shah‐Jalal Sarker's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3647.7%
- Health Sciences3444.7%
- Medicine3444.7%
- Life Sciences67.6%
- 1Surgery14% of their works
- 2Pulmonary and Respiratory Medicine14% of their works
- 3Oncology8% of their works
- 4Molecular Biology8% of their works
- 5Public Health, Environmental and Occupational Health5% of their works
- 6Epidemiology4% of their works
Research topics
Which keywords describe Shah‐Jalal Sarker's research?
The keywords of their largest research topics: Treatment, Immunotherapy, Therapy, Metastatic, Metastatic Breast Cancer, Renal Cell Carcinoma, Germ Cell Tumors and Testicular Cancer.
- mTOR
- Signaling
- Chemotherapy-Induced Peripheral Neuropathy
- Nephrogenesis
- CDK4/6 Inhibitors
- Pediatric Quality of Life Inventory
- Testicular Cancer
- Renal Cell Carcinoma
- Metastatic
- Immunotherapy
- Treatment
- Therapy
- Metastatic Breast Cancer
- Germ Cell Tumors
- Childhood Cancer Survivor Study
- Breast Cancer
- Kidney Organoids
- ALK
- Neuroblastoma
- Taxanes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Treatment162 topics
- Immunotherapy132 topics
- Therapy132 topics
- Metastatic91 topic
- Metastatic Breast Cancer92 topics
- Renal Cell Carcinoma91 topic
- Germ Cell Tumors71 topic
- Testicular Cancer71 topic
- Childhood Cancer Survivor Study61 topic
- Pediatric Quality of Life Inventory61 topic
- Breast Cancer51 topic
- CDK4/6 Inhibitors51 topic
- Kidney Organoids51 topic
- Nephrogenesis51 topic
- ALK41 topic
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- Neuroblastoma41 topic
- Signaling41 topic
- Taxanes41 topic
- mTOR41 topic
Where does Shah‐Jalal Sarker work?
Shah‐Jalal Sarker's main affiliation in the publication record is Queen Mary University of London, United Kingdom.
How many publications and citations does Shah‐Jalal Sarker have?
OpenAlex counts 76 works and 1,811 citations for Shah‐Jalal Sarker, an h-index of 20, ranking #1,843,653 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shah‐Jalal Sarker. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.